| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |